Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
32.39
-0.59 (-1.80%)
At close: Apr 28, 2026, 4:00 PM EDT
32.62
+0.23 (0.71%)
After-hours: Apr 28, 2026, 6:39 PM EDT
Viking Therapeutics Employees
Viking Therapeutics had 53 employees as of December 31, 2025. The number of employees increased by 17 or 47.22% compared to the previous year.
Employees
53
Change (1Y)
17
Growth (1Y)
47.22%
Revenue / Employee
n/a
Profits / Employee
-$6,785,642
Market Cap
3.75B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Crinetics Pharmaceuticals | 594 |
| Travere Therapeutics | 497 |
| Structure Therapeutics | 220 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 146 |
VKTX News
- 6 days ago - Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026 - PRNewsWire
- 18 days ago - Viking Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735 - PRNewsWire
- 7 weeks ago - Viking Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Viking Therapeutics Stock Gains Amid Obesity Drug Buzz - Benzinga
- 2 months ago - Viking Therapeutics plans to advance oral obesity drug to late-stage trial - Reuters
- 2 months ago - Viking Therapeutics Stock Climbs After Q4 Report: Details - Benzinga
- 2 months ago - Viking Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts